Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
345 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (1)

Medical Condition

  • Show all (309)
  • Addiction (2)
  • Autoimmune Disorders (1)
  • Blood Disorders (1)
  • Cancer (41)
    • Brain Cancer (25)
    • Breast Cancer (1)
    • Leukemia (2)
    • Lung Cancer (3)
    • (-) Lymphoma (1)
    • Skin Cancer (1)
  • COVID-19 (Coronavirus) (1)
  • Developmental Disorders (2)
  • Ear, Nose and Throat (3)
  • Endocrine & Metabolic Disease (1)
  • Eye (1)
  • Healthy Volunteers (35)
  • Heart Disease (1)
  • Infectious Disease (1)
  • Neurological Disorders (174)
  • Obstetrics & Gynecology (2)
  • Pediatrics (10)
  • Psychiatric Disorders (29)
  • Stroke (1)
  • Transplant (2)
    • (-) Liver Transplant (1)
    • Stem Cell Transplant (1)
  • Vascular Conditions (1)
Displaying 1 - 2 of 2

Characterizing Alzheimer's Disease & Related Dementias (ADRD) and risk for ADRD among liver transplant recipients with cognitive impairment

Condition: Transplant / Liver Transplant
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
The main purpose of this study is to deeply characterize cognitive function in liver transplant recipients, differentiate among different causes of cognitive impairment, and identify contributors to cognitive impairment. Participants will receive a comprehensive neurological exam, cognitive assessment, neuropsychological…
Read More

Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma (ZUMA-19)

Condition: Cancer / Lymphoma
Investigator: Ran Reshef, MD
Status: Closed
The purpose of this study is to find out if the experimental combination of lenzilumab (an antibody that blocks the cytokine GM-CSF) and axicabtagene ciloleucel (which is identical to the FDA-approved CAR-T cell product YESCARTA) helps in protecting patients from side effects of axicabtagene ciloleucel. While axicabtagene ciloleucel has been approved by the…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science